Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis

被引：0
作者：
Che-kai Tsao
Alexander C. Small
Max Kates
Erin L. Moshier
Juan P. Wisnivesky
Benjamin A. Gartrell
Guru Sonpavde
James H. Godbold
Michael A. Palese
Simon J. Hall
William K. Oh
Matthew D. Galsky
机构：
[1] Mount Sinai School of Medicine,Division of Hematology and Medical Oncology, The Tisch Cancer Institute
[2] Mount Sinai School of Medicine,Department of Medicine
[3] Texas Oncology,Department of Medicine, Section of Medical Oncology, Michael E. DeBakey Veterans Affairs Medical Center
[4] Baylor College of Medicine,Department of Urology
[5] Mount Sinai School of Medicine,undefined
来源：
World Journal of Urology | 2013年 / 31卷
关键词：
Cytoreductive nephrectomy; SEER; Targeted therapy; Tyrosine kinase inhibitor; Disparities;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1535 / 1539
页数：4
相关论文
共 75 条
  • [1] Coppin C(2005)Immunotherapy for advanced renal cell cancer Cochrane Database Syst Rev 1 CD001425-34
  • [2] Porzsolt F(1995)Cytoreductive surgery for stage IV renal cell carcinoma J Urol 154 32-1173
  • [3] Awa A(1998)Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma J Urol 159 1168-1659
  • [4] Kumpf J(2001)Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 1655-970
  • [5] Coldman A(2001)Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial Lancet 358 966-841
  • [6] Wilt T(2009)A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States Urology 74 837-600
  • [7] Bennett RT(2011)Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or disease related factors responsible? Urology 78 595-1053
  • [8] Lerner SE(2011)Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy Ann Oncol 22 1048-1812
  • [9] Taub HC(2012)Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA BJU Int 109 1807-1708
  • [10] Dutcher JP(2008)Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival J Urol 179 1704-1017
12345678